454 reports of this reaction
3.6% of all LORATADINE AND PSEUDOEPHEDRINE SULFATE reports
#3 most reported adverse reaction
DRUG EFFECT DECREASED is the #3 most commonly reported adverse reaction for LORATADINE AND PSEUDOEPHEDRINE SULFATE, manufactured by Bayer HealthCare LLC.. There are 454 FDA adverse event reports linking LORATADINE AND PSEUDOEPHEDRINE SULFATE to DRUG EFFECT DECREASED. This represents approximately 3.6% of all 12,600 adverse event reports for this drug.
Patients taking LORATADINE AND PSEUDOEPHEDRINE SULFATE who experience drug effect decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG EFFECT DECREASED is moderately reported among LORATADINE AND PSEUDOEPHEDRINE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to drug effect decreased, the following adverse reactions have been reported for LORATADINE AND PSEUDOEPHEDRINE SULFATE:
The following drugs have also been linked to drug effect decreased in FDA adverse event reports:
DRUG EFFECT DECREASED has been reported as an adverse event in 454 FDA reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG EFFECT DECREASED accounts for approximately 3.6% of all adverse event reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE, making it one of the most commonly reported side effect.
If you experience drug effect decreased while taking LORATADINE AND PSEUDOEPHEDRINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.